Market Whales and Their Recent Bets on HIMS Options
HIMSJune 3, 2025
Read more →Hims & Hers Health Stock Is Rising Tuesday: What's Going On?
HIMSHims & Hers Health Inc (NYSE:HIMS) shares are trading higher Tuesday after the company announced an acceleration of its global expansion through the acquisition of ZAVA.
June 3, 2025
Read more →Hims & Hers Announces Strategic Acquisition Of European Digital Health Leader ZAVA To Drive Major Growth In Key Markets
HIMSJune 3, 2025
Read more →Check Out What Whales Are Doing With HIMS
HIMSJune 2, 2025
Read more →Unpacking the Latest Options Trading Trends in Hims & Hers Health
HIMSMay 28, 2025
Read more →Hims & Hers Health Says New Customers Eligible For Wegovy Can Access Their Care For $549 Per Month For 6 Months
HIMSMay 22, 2025
Read more →Hims & Hers Health Stock Is Tumbling Thursday: What's Happening?
HIMSHims & Hers Health, Inc (NYSE:HIMS) is facing heavy selling pressure Thursday morning as the U.S. Food and Drug Administration's (FDA) ban of compounded drugs with semaglutide takes effect.
May 22, 2025
Read more →Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month
HIMSHims & Hers Health shares fell 4.1% Wednesday morning. Despite the pullback, the stock remains up an impressive 116% over the past month.
May 14, 2025
Read more →Hims & Hers Stock Soars 29% On Strong Q1 Earnings, Subscriber Growth
HIMSShares of Hims & Hers have gained 29% over the past week. The move higher has been driven by an impressive Q1 earnings report released last week.
May 13, 2025
Read more →Hims & Hers Stock Surges On Strong Q1 Results, Falls After Convertible Note Offering
HIMSHims & Hers Health shares have surged 17.4% this week. The company reported strong first-quarter earnings late Monday.
May 9, 2025
Read more →Reported Earlier, Hims & Hers Prices Upsized $870M Notes Due 2030 To Fuel Global Growth And AI-Driven Healthcare Expansion
HIMSMay 9, 2025
Read more →Hims & Hers Stock's 100% Surge Is Squeezing Shorts And It Might Just Be Getting Started
HIMSHedge funds shorting Hims & Hers Health Inc (NYSE:HIMS) may regret it - earnings with a positive surprise could lead to a short squeeze as stock continues to rise, up 96% in past month.
May 8, 2025
Read more →Hims & Hers Health Stock Is Sliding Thursday: What's Going On?
HIMSHims & Hers Health Inc (NYSE:HIMS) shares are falling Thursday morning after the company announced a proposed convertible senior notes offering.
May 8, 2025
Read more →Hims & Hers Health Announces Its Intention To Offer, Subject To Market And Other Conditions, $450M Aggregate Principal Amount Of Convertible Senior Notes Due 2030
HIMSMay 8, 2025
Read more →Hims & Hers Taps AI Expert Mo Elshenawy as New CTO to Scale Personalized Healthcare
HIMSMay 8, 2025
Read more →Hims & Hers Stock Soars 32% Since Tuesday On Strong Q1 Earnings And Robust Outlook
HIMSHims & Hers Health shares have surged 32.4% since Tuesday's session open. The stock is gaining following a standout first-quarter earnings report released late Monday.
May 7, 2025
Read more →Piper Sandler Reiterates Neutral on Hims & Hers Health, Raises Price Target to $39
HIMSMay 6, 2025
Read more →Citigroup Maintains Sell on Hims & Hers Health, Raises Price Target to $30
HIMSMay 6, 2025
Read more →What's Going On With Hims & Hers Stock Tuesday?
HIMSHims & Hers stock was trading lower but has since reversed and began trading higher after the company reported first-quarter earnings on Monday after the market closed.
May 6, 2025
Read more →Looking At Hims & Hers Health's Recent Unusual Options Activity
HIMSMay 6, 2025
Read more →Needham Reiterates Buy on Hims & Hers Health, Maintains $61 Price Target
HIMSMay 6, 2025
Read more →Hims & Hers Health Q1 Earnings: Revenue Jumps 111%, Subscribers Up 38%, Q2 Guidance Falls Short Of Estimates, Shares Slide
HIMSHims & Hers Health reports first-quarter revenue of $586.01 million, beating estimates of $538.2 million, according to Benzinga.
May 5, 2025
Read more →Hims & Hers Health Affirms FY2025 Sales Guidance of $2.30B-$2.40B vs $2.32B Est
HIMSMay 5, 2025
Read more →Hims & Hers Health Sees Q2 Sales $530.000M-$550.000M vs $564.56M Est
HIMSMay 5, 2025
Read more →Hims & Hers Health Q1 EPS $0.20 Beats $0.12 Estimate, Sales $586.01M Beat $538.20M Estimate
HIMSMay 5, 2025
Read more →Hims & Hers Appoints Nader Kabban As Chief Operations Officer
HIMSMay 5, 2025
Read more →12 Health Care Stocks Moving In Tuesday's Intraday Session
HIMSApril 29, 2025
Read more →B of A Securities Maintains Underperform on Hims & Hers Health, Raises Price Target to $26
HIMSApril 29, 2025
Read more →Hims & Hers Stock Surges As It Collaborates With Novo Nordisk To Sell Weight Loss Drug Wegovy On Its Platform
HIMSHims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care and revenue strategy.
April 29, 2025
Read more →Crude Oil Down Over 2%; Pfizer Shares Gain After Q1 Earnings
HIMSApril 29, 2025
Read more →Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Lowers Price Target to $40
HIMSApril 29, 2025
Read more →TD Cowen Downgrades Hims & Hers Health to Hold, Lowers Price Target to $30
HIMSApril 29, 2025
Read more →Novo Nordisk And Hims & Hers Health Announced A Long-term Collaboration For A Bundled Offering Of Novo Nordisk's FDA-Approved Wegovy On The Hims & Hers Platform
HIMSApril 29, 2025
Read more →Breaking Down Hims & Hers Health: 13 Analysts Share Their Views
HIMSApril 25, 2025
Read more →Citigroup Maintains Sell on Hims & Hers Health, Lowers Price Target to $25
HIMSApril 25, 2025
Read more →Is the Market Bullish or Bearish on Hims & Hers Health?
HIMSApril 21, 2025
Read more →Truist Securities Maintains Hold on Hims & Hers Health, Lowers Price Target to $33
HIMSApril 10, 2025
Read more →What's Driving the Market Sentiment Around Hims & Hers Health?
HIMSApril 2, 2025
Read more →nCino Posts Weak Earnings, Joins Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
HIMSApril 2, 2025
Read more →Newsmax, Waton Financial, Johnson & Johnson, Hims & Hers Health, Tesla: Why These 5 Stocks Are On Investors' Radars Today
HIMSU.S. stocks closed higher on Tuesday, with the Nasdaq Composite climbing 0.9% to 17,449.89. The S&P 500 added nearly 0.4%, finishing at 5,633.07.
April 2, 2025
Read more →Hims & Hers Health Stock Jumped Tuesday Afternoon: What Happened?
HIMSHims & Hers Health Inc (NYSE:HIMS) shares spiked higher in afternoon trading Tuesday after the company said it will offer Eli Lilly And Co's (NYSE:LLY) Zepbound through its Telehealth platform.
April 1, 2025
Read more →Hims To Sell Lilly's Zepbound Through Telehealth Platform
HIMSApril 1, 2025
Read more →Smart Money Is Betting Big In HIMS Options
HIMSMarch 28, 2025
Read more →Hims & Hers Health's Options Frenzy: What You Need to Know
HIMSMarch 19, 2025
Read more →B of A Securities Maintains Underperform on Hims & Hers Health, Raises Price Target to $22
HIMSMarch 18, 2025
Read more →Wisconsin Congressman Tony Wied Purchased $15K-$50K And $100K-$250K Of Hims & Hers Health; Sold $50K-$100K Of Tractor Supply Co; Sold $100K-$250K Charles Schwab Corp; Purchased $100K-$250K Block, Inc.; Sold $100K-$250K Of Monster Beverage Corp; Purchased
HIMSMarch 17, 2025
Read more →Defiance Launches RKLX And HIMZ ETFs For 2X Exposure To Rocket Lab, Hims & Her
HIMSMarch 13, 2025
Read more →Check Out What Whales Are Doing With HIMS
HIMSMarch 12, 2025
Read more →'Hims And Hers Just Shut Down Its Dermatology Business After Stock Slump On FDA's Weight-Loss Drug Decision' - Business Insider
HIMSMarch 7, 2025
Read more →Forecasting The Future: 15 Analyst Projections For Hims & Hers Health
HIMSMarch 6, 2025
Read more →